Jump to content

McKesson Corporation

From Wikipedia, the free encyclopedia
(Redirected from McKesson Corp.)
"McKesson" redirects here. For other uses, see McKesson (disambiguation).
McKesson Corporation
Formerly
  • Olcott (1828–1833)
  • Olcott & McKesson (1833–1853)
  • McKesson & Robbins (1853–1967)
  • McKessonHBOC (1999–2001)
Company typePublic
IndustryHealthcare
FoundedNew York City, U.S.
1833; 191 years ago (1833)
Founders
Headquarters
Irving, Texas
,
U.S.
Key people
Brian S. Tyler (CEO)
Products
RevenueIncrease US$308.9 billion (2024)
Decrease US$3.909 billion (2024)
Decrease US$3.002 billion (2024)
Total assetsIncrease US$67.44 billion (2024)
Total equityDecrease US$−1.97 billion (2024)
Number of employees
c. 51,000 (2024)
Subsidiaries
WebsiteMcKesson.com
Footnotes / references
Financials as of March 31, 2024.[1]

McKesson Corporation is a publicly-traded American company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 51,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a member of the S&P 500 and New York Stock Exchange, where it is traded under the ticker symbol NYSE: MCK.

McKesson provides extensive network of infrastructure for the healthcare industry and was an early adopter of technologies, including barcode scanning for distribution, pharmacy robotics, and RFID tags.[2] The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States.[3]

Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the United States of America Government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over a billion doses across the United States.[4][5]

History

[edit]

19th century

[edit]

McKesson was founded in 1828 in New York City as Charles M. Olcott by Charles M. Olcott. It was later renamed Olcott, McKesson & Co. and John McKesson in 1833,[6] the business began as an importer and wholesaler of botanical drugs. A third partner, Daniel Robbins, who joined the enterprise as it grew, and who previously "was an assistant to the original partners",[7] was the "Robbins" when the company was renamed McKesson & Robbins following Olcott's death in 1853.

20th century

[edit]
Further information: McKesson and Robbins scandal

The company successfully emerged from the McKesson and Robbins scandal under CEO Phillip Musica, one of the most notorious business and accounting scandals of the 20th century, a watershed event that led to major changes in American auditing standards and securities regulations after being exposed in 1938.

In 1967, Foremost Dairies, a company founded by James Cash Penney, which was headquartered in San Francisco since 1954, acquired McKesson & Robbins in a hostile takeover[8] to form Foremost-McKesson Inc.[9] The Foremost dairy operations were sold in 1982 and the name changed to McKesson Corporation but headquarters remained in San Francisco.[10]

In 1999, McKesson acquired medical information systems firm HBO & Company (HBOC).[11][12] The combined firm operated as McKessonHBOC for two years.[13] Accounting irregularities at HBOC reduced the company's share price by half, and resulted in the dismissal and prosecution of many HBOC executives.[12]

21st century

[edit]
The company's former headquarters at McKesson Plaza in San Francisco; in 2019, it relocated to Irving, Texas

In 2001, the company's name reverted to McKesson.[14] In the early 21st century, McKesson increased its market in medical technology through acquisitions, including Per Se Technologies and RelayHealth in 2006[15][16] and Practice Partner in 2007.[17]

On January 6, 2006, McKesson acquired NDCHealth Corporation.[18]

In 2010, McKesson acquired the oncology and physician services company US Oncology, Inc. for $2.16 billion, which was integrated into the McKesson Specialty Health business.[19]

In April 2012, McKesson agreed to pay the United States $190M to settle allegations that it had inflated prices and overbilled Medicaid.[20] Three months later, in July 2012, McKesson agreed to pay California and 28 other states $151M to settle allegations that it had inflated prices and overbilled Medicaid.[21]

On June 24, 2013, The Wall Street Journal reported that McKesson Chairman and CEO John Hammergren's pension benefits of $159 million had set a record for "the largest pension on file for a current executive of a public company, and almost certainly the largest ever in corporate America".[22]

In 2014, McKesson acquired Celesio to become one of the world's largest health care companies, with over $179 billion in annual revenue.[23]

In June 2016, McKesson announced plans to merge its IT business with Change Healthcare.[24]

In 2017, McKesson was involved in a number of lawsuits against the state of Arkansas over the supply of vecuronium bromide. McKesson was under contract by Pfizer not to sell to any correctional facility that authorized and carried out capital punishment.[25][26]

In November 2018, the company announced it would relocate its headquarters from San Francisco to Irving, Texas, effective April 1, 2019.[27] [28] Also in April 2019, Brian Tyler took over as CEO of the company.[29]

In February 2020, McKesson Corp announced that it would part ways with Change Healthcare.[30] McKesson gave up its ownership in the company and its three seats on the company's board of directors.[30]

Opioid epidemic

[edit]
Further information: Opioid epidemic

In 2008, McKesson paid $13 million in fines for failing to report large orders of hydrocodone.[31] In January 2017, McKesson agreed to pay a $150 million civil penalty for alleged similar violations of the Controlled Substances Act regarding the distribution of opioids.[32]

In January 2017, McKesson agreed to pay $150M to settle allegations that it had not done enough to track and stop suspicious opioid sales.[33] The agreement also obligated McKesson to suspend all sales of controlled substances from its distribution centers in Colorado, Florida, Ohio, and Michigan for multiple years.

In May 2020, Attorney General of Oklahoma Michael J. Hunter sued McKesson in Bryan County District Court, alleging that the company's actions helped fuel Oklahoma's opioid crisis. The suit was filed along with lawsuits against Cardinal Health and AmerisourceBergen, and the three lawsuits allege that the three companies provided "enough opioids to Bryan County that every adult resident there could have had 144 hydrocodone tablets."[34]

In January 2022, McKesson, AmerisourceBergen, Cardinal Health, and Johnson & Johnson agreed to pay $26 billion to settle with all but five of the states suing them.[35] Had the states gone to court, the companies could have faced up to $95 billion in penalties.[36]

COVID-19 pandemic

[edit]

In August 2020, during the COVID-19 pandemic, the CDC and HHS selected McKesson as the U.S. government's centralized distributor for COVID-19 vaccine doses and ancillary supply kits under Operation Warp Speed.[37][4] The company has played a key role in distributing the Moderna and Johnson & Johnson vaccines while also distributing ancillary supply kits for these as well as for the Pfizer–BioNTech vaccine across the U.S. (in addition to supporting the U.S. government in efforts to send doses and kits abroad).[38][5]

Finances

[edit]

For the fiscal year 2023, McKesson reported earnings of US$3.56 billion on revenue of US$276.711 billion.[39] As of 2023, McKesson was the nation's largest health care company and the ninth-largest company by total revenue on the Fortune 500.[40]

Year Revenue
(US$M) 		Net income
(US$M) 		Total assets
(US$M) 		Price per share
(US$) 		Employees
2005 79,096 −157 18,775 36.41
2006 86,983 751 20,961 44.00
2007 92,977 913 23,943 51.66
2008 101,703 990 24,603 45.79
2009 106,632 823 25,267 43.23
2010 108,702 1,263 28,189 57.52 32,500
2011 112,084 1,202 30,886 71.40 32,500
2012 122,321 1,403 33,093 80.91 36,400
2013 122,196 1,338 34,786 113.59 43,500
2014 137,392 1,263 51,759 173.29 42,800
2015 179,045 1,476 53,870 198.26 70,400
2016 190,884 2,258 56,523 156.90 68,000
2017 198,533 5,070 60,969 141.87 78,000
2018 208,357 67 60,381 132.29 78,000
2019 214,319 34 59,672 127.96 80,000
2020 231,051 900 61,247 148.34 80,000
2021 238,228 −4,539 65,015 195.88 76,000
2022 263,966 1,114 63,298 325.94 75,000
2023 276,711 3,560 62,320 405.02 51,000

Divisions

[edit]

McKesson Provider Technologies

[edit]

McKesson Provider Technologies is the retail name for McKesson Technology Solutions; the software development division of McKesson. Their customer base in the United States includes 50% of all health systems, 20% of all physician practices, 25% of home care agencies, and 77% of health systems with more than 200 beds.

On June 20, 2005, McKesson Provider Technologies acquired Medcon, Ltd., an Israeli company which provides web-based cardiac image and information management solutions for heart centers, that includes: diagnostic digital image management, archiving, procedure reporting, and workflow management.[41]

In October 2013, McKesson agreed to buy a 50% stake in Germany-based Celesio for $8.3 billion.[42]

McKesson Medical Supplies and Equipment

[edit]
McKesson Medical-Surgical Corporate campus in Richmond, Virginia
McKesson Medical-Surgical Corporate campus in Richmond, Virginia

McKesson Medical-Surgical (MMS) offers a large selection of national health care brands, along with McKesson's exclusive brand of medical products.

Their online medical supply ordering platform serves the needs of physician offices, surgery centers, home health agencies, DMEs, labs, and long-term-care facilities.[43]

In 2015, McKesson Medical-Surgical opened its new headquarters in Richmond, Virginia.[44]

Health Mart pharmacy franchise

[edit]
Further information: Health Mart
McKesson Pharmacy Systems in Livonia, Michigan

Health Mart, a network of over 4,000[45] independently owned and operated pharmacies, is a wholly owned subsidiary of McKesson Corporation, which owns the name "Health Mart". McKesson acquired Health Mart owner FoxMeyer in October 1996.[46]

Former divisions

[edit]

Mosswood Wine Company

McKesson operated the Mosswood Wine Company from 1978 until 1987, when the division was sold to maintain their focus on pharmaceuticals. The division was founded and run by wine writer Gerald Asher.[47]

NDCHealth (Relay Health)

[edit]

NDC (from the initials of its former identity as National Data Corporation) became NDC-Health Corp in 2001 following the spin-off of its payments division, Global Payments, in 2000.[48] NDCHealth was acquired by McKesson in 2007 through the purchase of Per-Se Technologies at which time it began doing business as RelayHealth in 2007.

International

[edit]

McKesson Canada

[edit]
McKesson Canada

In 1991, McKesson Corporation acquired a 100 percent interest in Medis Health and Pharmaceutical Services from Provigo. In 2002, the McKesson Canada name was adopted. McKesson Canada is a wholly owned subsidiary of McKesson Corporation. It includes various business units: McKesson Pharmaceutical, McKesson Automation, McKesson Specialty, McKesson Health Solutions and McKesson Information Solutions.

In 2012, McKesson agreed to purchase Canadian pharmacy chains IDA, Guardian Pharmacy, and The Medicine Shoppe from the Katz Group of Companies for $920 million.[49]

In March 2016, McKesson agreed to purchase Canadian pharmacy chain Rexall from the Katz Group of Companies for $3 billion.[50] The deal was finalized in December 2016 following approval received under the Investment Canada Act.[51]

On April 12, 2017, it was announced that McKesson Canada reached a deal to acquire 330 Uniprix pharmacies.[52]

In May 2018, McKesson Canada closed 40 Rexall locations in Ontario and Western Canada.[53]

United Kingdom

[edit]

In the United Kingdom, McKesson, operating as McKesson Information Solutions UK Ltd, was a provider of information technology services to the health care industry. In addition to numerous clinical software systems and finance and procurement services, McKesson also was responsible for developing the Electronic Staff Record system for the National Health Service which provided an integrated payroll system for NHS's 1.3 million staff, making it the world's largest single payroll IT system. McKesson Shared Services also provided payroll services for over 20 NHS Trusts, paying over 100,000 NHS members.

McKesson's United Kingdom base was in Warwick with data centers in Newcastle upon Tyne and Brent Cross and offices in Sheffield, Bangor, Glasgow and Vauxhall, London. Across the United Kingdom, it employed over 500 people.

In 2014, McKesson sold most of their healthcare software business to the private equity firm Symphony Technology Group and indicated also that they would not be re-bidding for the Electronic Staff Record contract.[54][55] This came after the company had posted significant year on year losses in revenue (16% in the 2012/13 financial year[56]) after taking over a very successful British operation in 2011.[57]

In April 2022, McKesson UK was acquired by the private equity company, Aurelius Group in a £477m deal. The companies acquired by Aurelius include LloydsPharmacy, and AAH Pharmaceuticals.[58]

Australia and New Zealand

[edit]

In 2010, McKesson Asia-Pacific was acquired by Medibank Private Ltd.[59][60]

McKesson ANZ is a fully owned subsidiary of McKesson Corporation. McKesson expanded its footprint in Australia and New Zealand by acquiring Emendo in November 2012.[61] McKesson ANZ develops and sells healthcare optimization services and software. The company has traditionally been focused on the public markets in Australia and New Zealand. The majority of the District Health Boards in NZ use one or more of McKesson's Capacity Management solutions.

Christchurch in New Zealand, is one of McKesson's global Capacity Management R&D centers of excellence. All of McKesson's R&D for McKesson Capacity Planner is performed in New Zealand. The company employs approximately 40 team members across Australia and New Zealand, including general management, R&D, sales, services, and support employees.

McKesson Capacity Planne, formerly Emendo CapPlan, is used in more than 40 hospitals in Australia, New Zealand, Britain, Canada, and the U.S.[62] to forecast future patient activity and help health systems to allocate resources efficiently and identify unnecessary costs.[61][63]

Germany

[edit]

On November 2, 2020, Walgreens Boots Alliance (WBA) and McKesson announced the completion of their previously announced agreement to create a joint venture combining their respective pharmaceutical wholesale businesses in Germany, Alliance Healthcare Deutschland (AHD) and GEHE Pharma Handel (GEHE). WBA holds a 70 percent controlling equity interest in the joint venture and McKesson holds the remaining 30 percent interest.[64]

See also

[edit]

References

[edit]
  1. ^ "FY 2024 Annual Report (Form 10-K)". U.S. Securities and Exchange Commission. May 8, 2024. pp. 9, 60, 62.
  2. ^ Mitchell, Luke (February 1, 2009). "Sick in the Head". Harper's Magazine. Archived from the original on May 25, 2017. Retrieved April 24, 2017.
  3. ^ Leggate, James (July 22, 2020). "What is McKesson?". FOXBusiness. Retrieved May 6, 2021.
  4. ^ a b Terry, Mark. "Operation Warp Speed Selects McKesson for COVID-19 Vaccine Distribution". BioSpace. Retrieved 10 December 2021.
  5. ^ a b "McKESSON REPORTS FISCAL 2022 FOURTH-QUARTER AND FULL-YEAR RESULTS" (PDF). McKesson Investor Relations. Retrieved May 5, 2021.
  6. ^ McKesson & Robbins, First Aid In Emergencies, 1930, p. 63.
  7. ^ David Morrell (January 22, 2010). "San Francisco's McKesson: 'The largest company no one has heard of'". East Bay Times. Archived from the original on Jul 13, 2022.
  8. ^ [Everybody's Business 1st edition (Milton Moskowitz, Michael Katz, Robert Levering, editors) Harper & Row, 1980 page 815]
  9. ^ "History of McKesson Corporation". mckesson.com. Archived from the original on April 24, 2015. Retrieved April 20, 2015.
  10. ^ Ap (September 3, 1982). "Foremost Dairies". The New York Times. ISSN 0362-4331. Archived from the original on May 24, 2015. Retrieved March 10, 2019.
  11. ^ Gomes, Lee (October 19, 1998). "McKesson Agrees to Acquire HBO & Co. for $14.46 Billion". Wall Street Journal. ISSN 0099-9660. Retrieved September 3, 2020.
  12. ^ a b "Former executives of HBO & Co. indicted on accounting fraud charges - Sep. 28, 2000". CNN. September 28, 2000. Retrieved September 3, 2020.
  13. ^ "McKesson Drops HBOC From Name". Los Angeles Times. July 26, 2001. Retrieved September 3, 2020.
  14. ^ Milt Freudenheim (January 13, 2005). "McKesson Agrees to Pay $960 Million in Fraud Suit". The New York Times. Archived from the original on May 31, 2013. Retrieved March 17, 2008.
  15. ^ "McKesson to acquire Per-Se Technologies". Los Angeles Times. November 7, 2006. Retrieved September 3, 2020.
  16. ^ "McKesson acquires RelayHealth". Modern Healthcare. June 12, 2006. Retrieved September 3, 2020.
  17. ^ "McKesson acquires Practice Partner". Modern Healthcare. February 28, 2007. Retrieved September 3, 2020.
  18. ^ Urbanowicz, Nicole (November 6, 2006). "2nd UPDATE: McKesson To Buy Per-Se For $1.8 Billion, $28/Share - Nov. 6, 2006". money.cnn.com. DOW JONES NEWSWIRES. Retrieved 2024-07-25.
  19. ^ Whelan, David. "Why Did McKesson Buy U.S. Oncology?". Forbes. Retrieved September 3, 2020.
  20. ^ "McKesson Corp. Pays U.S. More Than $190 Million to Resolve False Claims Act Allegations". www.justice.gov. 2012-04-26. Retrieved 2022-02-21.
  21. ^ "Attorney General Kamala D. Harris Recovers $23.5 Million in Settlement with McKesson Over Inflated Prescription Drug Prices". State of California - Department of Justice - Office of the Attorney General. 2012-07-26. Retrieved 2022-02-21.
  22. ^ Mark Maremont (June 25, 2013). "McKesson CEO Is Due $159 Million Pension". The Wall Street Journal. Archived from the original on April 27, 2015. Retrieved April 20, 2015.
  23. ^ "McKesson Launches Public Takeover Offer for Celesio | McKesson". www.mckesson.com. Archived from the original on August 7, 2018. Retrieved January 21, 2019.
  24. ^ Kennedy, Eleanor (June 28, 2016). "Change Healthcare merger to create health IT giant". Nashville Business Journal.
  25. ^ "Can big pharma stop the Arkansas mass executions?". The Guardian. April 16, 2017. Archived from the original on April 21, 2017. Retrieved April 21, 2017.
  26. ^ Supplier: Drug sold to Arkansas not intended for executions Archived April 22, 2017, at the Wayback Machine | CBS News
  27. ^ "McKesson, nation's sixth largest company, is moving corporate HQ from California to Irving". Dallas News. November 30, 2018. Archived from the original on December 4, 2018. Retrieved December 4, 2018.
  28. ^ "Brian Tyler Becomes McKesson's New CEO - McKesson". www.mckesson.com. Archived from the original on April 12, 2019. Retrieved April 12, 2019.
  29. ^ Schneider, Rob (December 6, 2019). "'Don't Debate It For 40 Years, Do It' Brian Tyler, McKesson". Dallas Business Journal.
  30. ^ a b Stinnett, Joel (February 5, 2020). "Three years after merger, McKesson to part ways with Change Healthcare". Nashville Business Journal. Retrieved March 3, 2020.
  31. ^ Bill Whittaker (December 17, 2017). "Whistleblowers: DEA attorneys went easy on McKesson, the country's largest drug distributor". CBS News. Archived from the original on December 24, 2017. Retrieved December 24, 2017.
  32. ^ "McKesson Corp, Form DEF 14A, Filing Date Jun 16, 2017" (PDF). SECdatabase.com. Archived (PDF) from the original on April 24, 2018. Retrieved April 23, 2018.
  33. ^ "McKesson Agrees to Pay Record $150 Million Settlement for Failure to Report Suspicious Orders of Pharmaceutical Drugs". www.justice.gov. 2017-01-17. Retrieved 2022-02-21.
  34. ^ "Attorney General Hunter Refiles Lawsuits against Three Leading Opioid Distributors | Oklahoma Attorney General". oag.ok.gov. Retrieved 2022-03-12.
  35. ^ Raymond, Nate (2022-01-27). "Most U.S. local governments opt to join $26 bln opioid settlement". Reuters. Retrieved 2022-02-21.
  36. ^ Raymond, Nate (2021-11-16). "Washington state, in $95 billion opioid trial, blames drug distributors for crisis". Reuters. Retrieved 2022-02-21.
  37. ^ Raimonde, Olivia (Aug 14, 2020). "McKesson to Distribute Virus Vaccine Under Existing U.S. Pact". Bloomberg LP. Retrieved 10 December 2021.
  38. ^ "A Look Into Our COVID-19 Vaccine Ancillary Supply Kit Operation". McKesson Corp.
  39. ^ "Financial Information | McKesson Investor Relations". investor.mckesson.com. Archived from the original on January 14, 2019. Retrieved November 7, 2018.
  40. ^ "Fortune 500 Companies 2018: Who Made the List". Fortune. Archived from the original on November 10, 2018. Retrieved November 9, 2018.
  41. ^ McKesson Completes Acquisition of Medcon Ltd. | Business Wire Archived December 3, 2013, at the Wayback Machine August 15, 2005
  42. ^ Burger, Ludwig (October 24, 2013). "McKesson $8.3 billion deal for drugs trader Celesio to create market leader". Reuters. Archived from the original on September 24, 2015. Retrieved July 1, 2017.
  43. ^ "McKesson Medical Supplies and Equipment". Archived from the original on January 21, 2019. Retrieved March 1, 2018.
  44. ^ Gilligan, Gregory J. "McKesson Medical-Surgical opens its new headquarters". Richmond Times-Dispatch. Retrieved January 12, 2018.
  45. ^ "Health Mart Pharmacy of the Year Spotlight". healthmart.com.
  46. ^ "McKesson Corp, Form 8-K, Current Report, Filing Date Nov 22, 1996". secdatabase.com. Archived from the original on April 24, 2018. Retrieved April 23, 2018.
  47. ^ "The Stout Report: Eggs Florentine, Gavi and Breakfast with Gerald Asher". theblendblog.com. Archived from the original on June 1, 2013.
  48. ^ "National Data Corp. changes name to NDCHealth Corp". Atlanta Business Chronicle. October 30, 2001. Retrieved June 24, 2020.
  49. ^ "Katz Group to sell part of business to U.S. firm". CBC News. 30 January 2012. Archived from the original on 21 March 2024. Retrieved 21 March 2024.
  50. ^ Strauss, Marina (March 2, 2016). "Rexall takeover shakes up Canada's drugstore industry". The Globe and Mail. Archived from the original on August 26, 2017. Retrieved September 4, 2017.
  51. ^ "McKesson Completes Acquisition of Rexall Health and Appoints Domenic Pilla as CEO of McKesson Canada | McKesson Investor Relations". investor.mckesson.com. Archived from the original on January 21, 2019. Retrieved July 17, 2018.
  52. ^ "McKesson Canada reaches deal to acquire 330 Uniprix pharmacies". Montreal Gazette. The Canadian Press. April 12, 2017. Retrieved June 16, 2024.
  53. ^ "Rexall closing after less than 5 years in London's downtown core". 980 CFPL. Archived from the original on July 17, 2018. Retrieved July 17, 2018.
  54. ^ Jon Hoeksma (May 8, 2013). "McKesson UK put up for sale". ehiNEWS. Archived from the original on April 3, 2015. Retrieved March 26, 2015.
  55. ^ Jon Hoeksma (June 2, 2014). "Symphony buys McKesson UK health ops". ehiNEWS. Archived from the original on April 2, 2015. Retrieved March 26, 2015.
  56. ^ "Article: Symphony Technology Group snaps up McKesson divestments". HealthInvestor. Archived from the original on September 25, 2015. Retrieved January 2, 2016.
  57. ^ "McKesson To Acquire British Software Vendor System C | HIStalk". Histalk2.com. March 3, 2011. Archived from the original on September 23, 2015. Retrieved January 2, 2016.
  58. ^ Craft, Mark (8 April 2022). "Aurelius Completes Acquisition Of LloydsPharmacy And AAH - KamCity". Retrieved 2022-04-08.
  59. ^ "McKesson to Sell Its McKesson Asia-Pacific Business to Medibank Private Ltd". Archived from the original on April 13, 2016. Retrieved March 30, 2016.
  60. ^ "Medibank finalises acquisition of McKesson Asia-Pacific". Archived from the original on April 8, 2016. Retrieved March 30, 2016.
  61. ^ a b "McKesson NZ aims for growth with plans to add staff and products - Computerworld New Zealand". Computerworld.co.nz. May 23, 2014. Archived from the original on July 20, 2015. Retrieved July 30, 2015.
  62. ^ Tamlyn Stewart (November 8, 2012). "Pharma giant snaps up Emendo". Stuff.co.nz. Archived from the original on September 24, 2015. Retrieved July 30, 2015.
  63. ^ Tamlyn Stewart (November 7, 2012). "Fortune 500 firm buys Kiwi tech company". Stuff.co.nz. Archived from the original on September 24, 2015. Retrieved July 30, 2015.
  64. ^ "Walgreens Boots Alliance and McKesson Complete the Formation of German Wholesale Joint Venture". Mckesson.com. November 2, 2020. Retrieved November 2, 2020.
[edit]
  • Official website
  • Business data for McKesson Corporation:
  • McKesson Corporation: Company Overview & History
Retrieved from "https://en.wikipedia.org/w/index.php?title=McKesson_Corporation&oldid=1247648363"